Aeglea BioTherapeutics, Inc. (AGLE) - Stock Prices, Stock Peers & Analysis

Home
AGLE

Company Name	Aeglea BioTherapeutics, Inc.
Symbol	AGLE
Currency	USD
Price	12.01
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	48,627,649
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	2.66 - 24
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Jonathan D. Alspaugh M.B.A.
Website	https://www.aeglea.com

An error occurred while fetching data.

About Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for